alastair gray
alastair gray
Professor of Health Economics, University of Oxford
Verified email at dph.ox.ac.uk
Title
Cited by
Cited by
Year
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials
M Flather
The Lancet 376 (9753), 1670-1681, 2010
5454*2010
The economic burden of back pain in the UK
N Maniadakis, A Gray
Pain 84 (1), 95-103, 2000
17972000
The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials.
B Mihaylova, J Emberson, L Blackwell, A Keech, J Simes, EH Barnes, ...
Lancet (London, England) 380 (9841), 581-590, 2012
14872012
Economic burden of cardiovascular diseases in the enlarged European Union
J Leal, R Luengo-Fernández, A Gray, S Petersen, M Rayner
European heart journal 27 (13), 1610-1619, 2006
8882006
Economic evaluation in clinical trials
HA Glick, JA Doshi, SS Sonnad, D Polsky
OUP Oxford, 2014
8762014
European cardiovascular disease statistics 2012
M Nichols, N Townsend, R Luengo-Fernandez, J Leal, A Gray, ...
European Heart Network, 2012
8602012
European cardiovascular disease statistics
S Allender, P Scarborough, V Peto, M Rayner, J Leal, ...
European Heart Network 3, 11-35, 2008
7542008
Economic burden of cancer across the European Union: a population-based cost analysis
R Luengo-Fernandez, J Leal, A Gray, R Sullivan
The lancet oncology 14 (12), 1165-1174, 2013
7472013
A model to estimate the lifetime health outcomes of patients with type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68)
PM Clarke, AM Gray, A Briggs, AJ Farmer, P Fenn, RJ Stevens, ...
Diabetologia 47 (10), 1747-1759, 2004
6132004
Applied methods of cost-effectiveness analysis in healthcare
AM Gray, PM Clarke, JL Wolstenholme, S Wordsworth
Oxford University Press, 2011
5352011
Estimating utility values for health states of type 2 diabetic patients using the EQ-5D (UKPDS 62)
P Clarke, A Gray, R Holman
Medical Decision Making 22 (4), 340-349, 2002
5012002
European cardiovascular disease statistics
J Leal, R Luengo-Fernandez, A Gray
British Heart Foundation, 2000
4702000
Cost effectiveness of an intensive blood glucose control policy in patients with type 2 diabetes: economic analysis alongside randomised controlled trial (UKPDS 41)
A Gray, M Raikou, A McGuire, P Fenn, R Stevens, C Cull, I Stratton, ...
Bmj 320 (7246), 1373-1378, 2000
4342000
Handling uncertainty when performing economic evaluation of healthcare interventions
A Briggs
Health Technol Assess 3, 2, 1999
4201999
Randomised controlled trial comparing hospital at home care with inpatient hospital care. I: three month follow up of health outcomes
S Shepperd, D Harwood, C Jenkinson, A Gray, M Vessey, P Morgan
Bmj 316 (7147), 1786-1791, 1998
397*1998
Cost effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes: UKPDS 40
UK Prospective Diabetes Study Group
Bmj 317 (7160), 720-726, 1998
3841998
Measuring the impact of menopausal symptoms on quality of life.
E Daly, A Gray, D Barlow, K McPherson, M Roche, M Vessey
British medical journal 307 (6908), 836-840, 1993
3711993
Randomized trial to compare bilateral vs. single internal mammary coronary artery bypass grafting: 1-year results of the Arterial Revascularisation Trial (ART)
DP Taggart, DG Altman, AM Gray, B Lees, F Nugara, LM Yu, H Campbell, ...
European heart journal 31 (20), 2470-2481, 2010
3662010
A longitudinal study of the effects of age and time to death on hospital costs
M Seshamani, AM Gray
Journal of health economics 23 (2), 217-235, 2004
3662004
Ageing and health‐care expenditure: the red herring argument revisited
M Seshamani, A Gray
Health economics 13 (4), 303-314, 2004
3542004
The system can't perform the operation now. Try again later.
Articles 1–20